Discover the Latest Breakthrough in Cancer Treatment: Onconova Therapeutics to Unveil Rigosertib at the 2023 EADV Congress

Welcome to the Future of Cancer Treatment Onconova Therapeutics: Revolutionizing Patient Care It is with great excitement that Onconova Therapeutics, a leading biopharmaceutical company, has announced a groundbreaking development in the field of cancer treatment. The company’s latest research focuses on the use of rigosertib in patients with recessive dystrophic epidermolysis bullosa (RDEB) associated with…

Read More

Revving Up Support for Our Veterans: America’s Warrior Partnership and Pombo Jones Motorsports Join Forces

America’s Warrior Partnership and Pombo-Jones Motorsports announce partnership to support the veteran community In an effort to raise awareness for veteran suicide prevention, America’s Warrior Partnership (AWP) has recently partnered with Pombo-Jones Motorsports. This new collaboration aims to support AWP’s Indianapolis community branch program and spread awareness nationally about the issue of veteran suicide. Impact…

Read More

Kura Oncology Presents Preclinical Data Demonstrating KO-2806’s Potential to Boost Antitumor Effects of KRASᴳ¹² Inhibitors in Non-Small Cell Lung Cancer

Overview Recently, Kura Oncology, Inc. presented preclinical data at the RAS Summit showcasing the potential of their next-generation FTI in combination with KRASG12C inhibitors. The company also announced plans to include KRASG12C-mutant NSCLC in the combination portion of their Phase 1 clinical trial of KO-2806 (FIT-001). Advancements in Cancer Treatment The development of KO-2806 and…

Read More